Growth Metrics

10x Genomics (TXG) Other Working Capital Changes (2018 - 2026)

10x Genomics' Other Working Capital Changes history spans 7 years, with the latest figure at $3.7 million for Q4 2025.

  • On a quarterly basis, Other Working Capital Changes fell 64.0% to $3.7 million in Q4 2025 year-over-year; TTM through Dec 2025 was $2.3 million, a 347.99% increase, with the full-year FY2025 number at $2.3 million, up 347.99% from a year prior.
  • Other Working Capital Changes hit $3.7 million in Q4 2025 for 10x Genomics, up from $1.1 million in the prior quarter.
  • Over the last five years, Other Working Capital Changes for TXG hit a ceiling of $20.4 million in Q2 2023 and a floor of -$17.6 million in Q3 2023.
  • Historically, Other Working Capital Changes has averaged -$332550.0 across 5 years, with a median of $230000.0 in 2021.
  • The widest YoY moves for Other Working Capital Changes: up 1273.38% in 2023, down 2328.23% in 2023.
  • Tracing TXG's Other Working Capital Changes over 5 years: stood at -$1.1 million in 2021, then plummeted by 196.41% to -$3.4 million in 2022, then tumbled by 170.28% to -$9.1 million in 2023, then surged by 212.53% to $10.3 million in 2024, then crashed by 64.0% to $3.7 million in 2025.
  • Business Quant data shows Other Working Capital Changes for TXG at $3.7 million in Q4 2025, $1.1 million in Q3 2025, and $192000.0 in Q2 2025.